John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Symbotic
SYM
$5.25B
| $2.92M | 0.01% |
144,425
-177,197
| -55% | -$4.53M |
|
1427
Vanguard Health Care ETF
VHT
$19.8B
| $2.91M | 0.01% |
11,000
-106,700
| -91% | -$28.4M |
|
1428
Porch Group
PRCH
$1.98B
| $2.9M | 0.01% |
398,231
+201,104
| +102% | +$1.09M |
|
1429
iShares US Healthcare Providers ETF
IHF
$1.23B
| $2.9M | 0.01% |
54,922
-109,200
| -67% | -$5.61M |
|
|
NFBK
1430
DELISTED
Northfield Bancorp
NFBK
| $2.89M | 0.01% |
264,956
+67,434
| +34% | +$776K |
|
|
SBR
1431
Sabine Royalty Trust
SBR
$1.09B
| $2.89M | 0.01% |
42,628
+28,811
| +209% | +$1.92M |
|
|
EARN
1432
Ellington Residential Mortgage REIT
EARN
$166M
| $2.88M | 0.01% |
533,062
+301,479
| +130% | +$1.92M |
|
1433
Peoples Bancorp
PEBO
$1.42B
| $2.88M | 0.01% |
97,133
+43,070
| +80% | +$1.35M |
|
1434
Jackson Financial
JXN
$8.92B
| $2.88M | 0.01% |
+34,379
| New | +$3.05M |
|
1435
Xerox
XRX
$387M
| $2.87M | 0.01% |
594,458
+142,129
| +31% | +$1.07M |
|
1436
TransAlta
TAC
$3.87B
| $2.87M | 0.01% |
306,742
+292,950
| +2,124% | +$3.24M |
|
1437
Dimensional US Targeted Value ETF
DFAT
$14.6B
| $2.86M | 0.01% |
55,600
-55,300
| -50% | -$3.04M |
|
1438
Flowers Foods
FLO
$1.51B
| $2.86M | 0.01% |
150,223
-379,834
| -72% | -$7.26M |
|
1439
United Fire Group
UFCS
$1.38B
| $2.85M | 0.01% |
96,849
+31,130
| +47% | +$841K |
|
|
SAGE
1440
DELISTED
Sage Therapeutics
SAGE
| $2.85M | 0.01% |
358,385
+228,635
| +176% | +$1.67M |
|
1441
Alamo Group
ALG
$1.97B
| $2.85M | 0.01% |
15,965
+3,188
| +25% | +$585K |
|
1442
Acuity Brands
AYI
$10.2B
| $2.84M | 0.01% |
10,790
+503
| +5% | +$152K |
|
1443
Cirrus Logic
CRUS
$5.58B
| $2.84M | 0.01% |
28,510
-47,899
| -63% | -$4.94M |
|
1444
Primerica
PRI
$9.16B
| $2.83M | 0.01% |
9,962
-12,240
| -55% | -$3.49M |
|
|
FGMCU
1445
DELISTED
FG Merger II Corp Unit
FGMCU
| $2.83M | 0.01% |
+290,000
| New | +$2.84M |
|
1446
Credit Acceptance
CACC
$6.27B
| $2.83M | 0.01% |
5,480
-19,664
| -78% | -$9.73M |
|
|
TUYA
1447
Tuya Inc
TUYA
$1.1B
| $2.83M | 0.01% |
932,893
+148,271
| +19% | +$439K |
|
1448
Celestica
CLS
$38.7B
| $2.82M | 0.01% |
35,824
-272
| -0.8% | -$28.9K |
|
|
BLDP
1449
Ballard Power Systems
BLDP
$696M
| $2.82M | 0.01% |
2,565,303
+772,007
| +43% | +$1.09M |
|
1450
Liquidity Services
LQDT
$1.35B
| $2.82M | 0.01% |
90,941
-7,073
| -7% | -$235K |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.